Continuing to fight the fight on the other board:
Post# of 72440
(Total Views: 384)
Posted On: 02/11/2019 3:54:56 PM
Continuing to fight the fight on the other board:
I find it absolutely amazing that IPIX has been able to get to the current situation of having a major drug on the brink of signing a partnership for the first two of many indications and they did it with less than 200MM shares outstanding (or something close to that number) and debt of only $8MM.
How many companies having to deal in the high cost world of clinical trials could make it thru roughly 8 years or more with only $8MM in debt with no revenues ever? The lack of revenues is the curse of any startup bio dealing in trying to get new drugs approved by the FDA, not the fault of mgt.
This is a feather in the cap for mgt in my eyes, while in others they try to sell this as a major failing.
Kind of like crapping all over a man building a bridge by hand over a chasm that will be the only crossing point for 1000 miles and criticizing him for never accruing revenues prior to finishing the bridge when he only has a few feet left of the bridge to build to put it into operation.
In a matter of a few feet and a few days, he goes from a bum chasing a dream to a wealthy visionary providing a blessing to the area and all those needing to cross the chasm. I see such a man in Leo.
I find it absolutely amazing that IPIX has been able to get to the current situation of having a major drug on the brink of signing a partnership for the first two of many indications and they did it with less than 200MM shares outstanding (or something close to that number) and debt of only $8MM.
How many companies having to deal in the high cost world of clinical trials could make it thru roughly 8 years or more with only $8MM in debt with no revenues ever? The lack of revenues is the curse of any startup bio dealing in trying to get new drugs approved by the FDA, not the fault of mgt.
This is a feather in the cap for mgt in my eyes, while in others they try to sell this as a major failing.
Kind of like crapping all over a man building a bridge by hand over a chasm that will be the only crossing point for 1000 miles and criticizing him for never accruing revenues prior to finishing the bridge when he only has a few feet left of the bridge to build to put it into operation.
In a matter of a few feet and a few days, he goes from a bum chasing a dream to a wealthy visionary providing a blessing to the area and all those needing to cross the chasm. I see such a man in Leo.
(12)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼